Phase 1 Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been diagnosed with a retinal disease that involves breakdown of a layer in the eye called the retinal pigment epithelium (for example, geographic atrophy or Stargardt disease)
- Your level of vision falls within the specific range required by the trial (confirm with trial site)
- Your eye condition has been stable for a period of time before joining the trial (confirm with trial site for exact timeframe)
- You are healthy enough to safely undergo eye surgery and anesthesia
- You are willing and able to follow all study requirements and attend follow-up appointments
Who may not be able to join:
- You have or have had abnormal blood vessel growth under the retina (a condition called choroidal neovascularization)
- You have had a heart attack recently or have serious heart or blood vessel disease that is not well controlled
- You have glaucoma that is not well controlled
- You have significant inflammation or swelling inside your eye
- You have had eye surgery recently within a timeframe set by the trial (confirm with trial site for exact timeframe)
- You currently have an active infection anywhere in your body
- You have diabetes that is not well managed (specifically, a blood sugar control measurement called HbA1c above 8.5%)
- You have taken part in another clinical research study within the past 3 months before screening
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Ocular and Systemic Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.